Fetal Doppler Market Size, Share, and Industry Analysis, By Type (Pocket Size and Non-Pocket Size {Table-Mounted and Trolley-Mounted}), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

A fetal doppler is a handheld ultrasound transducer that is used to detect the fetal heartbeat during prenatal care. It uses the doppler Effect to provide an audible simulation of the fetal heart rate, allowing healthcare providers and pregnant individuals to listen to the fetal heartbeat. The device typically consists of a probe and a main unit connected by a cord, with the probe being placed on the abdomen to detect fetal sounds. Fetal dopplers are commonly used in healthcare settings but are also available for home use, which eliminates the time investment and money spent in hospitals and clinics.

The market growth is attributed to the growing prevalence of high-risk pregnancies globally. The risk of pregnancy complications, such as intrauterine growth restrictions and hypoxia, is prompting healthcare providers to use doppler ultrasound more frequently to monitor fetal health and detect potential issues early. This is expected to boost the market growth in the forthcoming years.

• For instance, as per the article published by the National Center for Biotechnology Information (NCBI) in September 2023, the prevalence of high-risk pregnancies among Indian women was 49.4%. Furthermore, the article reported that around 33.0% of women were at a single high-risk, and 16.4% were at multiple high-risk pregnancies.

Furthermore, ultrasound technology has become more widely available and accessible, leading to a greater awareness amongst pregnant women and healthcare providers regarding the benefits of fetal Doppler. The improved ultrasound technology and doppler devices have made it easier to detect fetal heartbeats and monitor fetal well-being. This is increasing its adoption in healthcare settings, which is expected to drive market growth during the forecast period. In addition, there is a rising demand for at-home fetal dopplers globally. This is primarily attributed to the increasing patient demand for involvement in care. Pregnant women are increasingly seeking more involvement in their care. They are interested in monitoring their baby's health more closely, which is expected to surge the market growth during the forecast timeframe.

Furthermore, the global availability of over-the-counter (OTC) fetal dopplers has made it easier for individuals to purchase these devices, thereby contributing to the growing demand for such devices. This is also expected to boost the market growth in the coming years.

The COVID-19 pandemic had a significant impact on the fetal doppler market. The market experienced an increase in demand for the remote monitoring of maternal and fetal health in 2020. In order to support this demand, several regulatory authorities issued guidelines regarding the use of non-invasive fetal monitoring devices, such as fetal doppler, during the pandemic. This increased accessibility and the need for remote monitoring contributed to the growth of the fetal doppler market during the pandemic.

• For instance, in June 2020, the Food and Drug Administration (FDA) issued an enforcement policy for the use of non-invasive fetal and maternal monitoring devices, including fetal ultrasonic monitors (i.e., fetal doppler), uterine electromyographic monitor, fetal phonocardiographic monitor during the pandemic.

Segmentation

Key Insights

The report covers the following key insights:

• Overview: Technological Advancements in the Fetal Dopplers
• Prevalence of Pregnancy-Risk Complications, By Key Countries/Region, 2023
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Impact of COVID-19 on the Market  

Analysis by Type

Based on the type, the market is segmented into pocket size and non-pocket size. The pocket segment is projected to account for a significant share of the global fetal doppler market during the forecast period. The growth of the segment is primarily attributed to the rising popularity of pocket fetal doppler globally, as they are designed for personal and at-home use by expectant mothers, providing a convenient and portable way to monitor their baby's heartbeat between prenatal appointments. These benefits or pocket doppler are stimulating the key players' focus on ensuring its availability worldwide. This is expected to boost the segment growth during the forecast period.

• For instance, as of June 2024, CONTEC MEDICAL SYSTEMS CO., LTD offers CONTEC10CL pocket fetal doppler to detect fetal heart rate at hospitals, clinics, and homes. The availability of such convenient products is expected to boost its demand, thereby propelling the segment's growth in the upcoming years.

On the other hand, the non-pocket segment is anticipated to grow at a noteworthy CAGR during the forecast period. The non-pocket fetal doppler, most often used at hospitals, provides a precise diagnostic ability compared to at-home pocket fetal doppler. This significantly provides more accurate detection of complications in maternal and fetal health, which is driving the demand for such devices. This is expected to boost the segment growth during the forecast timeframe.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the fetal doppler market during the forecast period. The market growth of this region is primarily attributed to the strict regulatory policies that ensure the high quality of fetal doppler and maintain patient safety in countries such as the U.S. In addition, well-established healthcare infrastructure is expected to boost the demand for fetal dopplers by enabling better access to prenatal care and increasing the affordability of these devices across the region. These factors are expected to boost the regional market growth in the forthcoming years.

• For instance, in April 2020, the U.S. FDA stated that the use of fetal/maternal monitoring devices should only be permitted with a prescription from a healthcare professional. In addition, the U.S. FDA also guided the changes in the labeling of over-the-counter (OTC) sales of such devices.

The Asia Pacific region is projected to grow at a significant CAGR during the forecast timeframe. The growth of the region is mainly attributed to the high burden of pregnancy complications in countries such as India and China. This high burden of maternal and fetal complications is encouraging the prominent players to increase the availability of fetal dopplers in the region. This is expected to increase product accessibility in the region, thereby propelling market growth in the coming years.

Key Players Covered

The market consists of significant players, such as CONTEC MEDICAL SYSTEMS CO., LTD, Huntleigh Healthcare Limited, Promed Technology Co., Limited, Hadeco, Inc., Bistos Co., Ltd., Avante Health Solutions, Gima S.p.A., and Ultrasound Technologies Ltd.

Key Industry Developments

• In January 2024, Bloomlife received U.S. FDA approval for its first maternal and fetal monitoring device, MFM-Pro, to help healthcare providers measure maternal and fetal heart rates in the patient's home or clinic.
• In March 2021, Huntleigh Healthcare Limited developed a new digital platform for its fetal dopplers, such as Dopplex DMX Vascular Doppler and Sonicaid SR Fetal Dopplers, to provide advanced features in the diagnosis of fetal health.